Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCharacter Regulatory News (CCT)

Share Price Information for Character (CCT)

Share Price is delayed by 15 minutes
Get Live Data
280.00    0.00 (0.00%)
Bid:
270.00
Ask:
290.00
Spread: 20.00 (7.407%)
Market Cap: £48.76m
CCT Live PriceLast checked at - London Stock Exchange

Intraday Character Share Chart

New Share Buyback Programme

2 Feb 2026 15:07

RNS Number : 3746R
Character Group PLC (The)
02 February 2026
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Monday, 2 February 2026

The Character Group plc

("Character," the "Company" or the "Group")

New Share Buyback Programme

Character (AIM:CCT) today announces the launch of a new share buyback programme (the "2026 Share Buyback Programme"), following the completion of its previous share buyback programme, pursuant to which approximately £3.0 million worth of ordinary shares of 5 pence each in the Company ("Ordinary Shares") were purchased on behalf of the Company between 29 October 2024 and 15 January 2026.

The Board continues to believe that the Company's share price significantly undervalues the Group. Therefore, to further enhance shareholder returns and to reduce the Company's share capital, the Board has today approved the 2026 Share Buyback Programme to repurchase Ordinary Shares for up to a maximum aggregate consideration of £3.0 million, which will be funded out of the Group's existing cash resources.

The 2026 Share Buyback Programme will be carried out pursuant to the approvals granted by shareholders at the Annual General Meeting held on 16 January 2026 (the "General Authority") and will commence on the date of this announcement and continue until either the maximum pecuniary amount has been purchased under the 2026 Share Buyback Programme or, if earlier, 14 January 2027. The 2026 Share Buyback Programme will also automatically terminate upon the Company giving notice that any person (or group of persons known to be acting in concert) has become interested in Ordinary Shares carrying 29% or more of the voting rights in the Company.

The Company has entered into an irrevocable commitment with Panmure Liberum Limited ("Panmure Liberum") to conduct the 2026 Share Buyback Programme and repurchase Ordinary Shares on the Company's behalf and to make trading decisions under the programme in accordance with certain pre-set parameters independently of the Company.

Share purchases under the 2026 Share Buyback Programme will take place in open market transactions and may be made from time to time depending on market conditions, share price, trading volume and other terms. The maximum price paid per Ordinary Share will be no more than: (i) the higher of the price of the last independent trade and the highest current independent purchase bid for Ordinary Shares on the trading venue where the purchase is carried out; and (ii) 105 per cent of the average closing middle market quotations of an Ordinary Share for the five business days immediately preceding the day on which such Ordinary Shares are purchased. Under the 2026 Share Buyback Programme, the shares repurchased by the Company will be cancelled.

 

There is no guarantee that the 2026 Share Buyback Programme will be implemented in full or that any purchases will be made. The Company reserves the right to bring a halt to the 2026 Share Buyback Programme under circumstances that it deems to be appropriate and in accordance with relevant law and regulation.

The 2026 Share Buyback Programme will be conducted within the pricing parameters of the Market Abuse Regulation 596/2014/EU and the delegated regulations made pursuant to it (the "Regulations"). However, given the limited liquidity in the issued Ordinary Shares, the Company has agreed that, on any trading day, a buy-back of Ordinary Shares under the 2026 Share Buyback Programme may exceed 25% but not more than 50% of the average daily trading volume in the Ordinary Shares in the 20 trading days preceding the date on which a buy-back of Ordinary Shares is carried out. Accordingly, the Company may not benefit from the exemption contained in the Regulations.

The Company will make further regulatory announcements in respect of repurchases of Ordinary Shares as required by UK MAR and the AIM Rules.

The Company confirms that it currently has no other unpublished price sensitive information at the time of this announcement.

 

The Character Group plc

FTSE sector: leisure goods:

FTSE AIM All-share: symbol: CCT

Market cap: £42m

Email:  info@charactergroup.plc.uk

Group website: www.thecharacter.com

Product ranges can also be viewed at www.character-online.co.uk

CHARACTER GROUP PLC CCT Stock | London Stock Exchange

 

 

Enquiries to:

The Character Group plc

Jon Diver, Joint Managing Director

Kiran Shah, Joint Managing Director

Hamun Shah, Group Finance Director

Office: +44 (0) 208 329 3377

Mobile: +44 (0) 7831 802219 (JD)

Mobile: +44 (0) 7956 278522 (KS)

Mobile: +44 (0) 7989 517315 (HS)

 

Panmure Liberum (Nominated Adviser and Joint Broker)

Atholl Tweedie, Investment Banking

Rupert Dearden, Corporate Broking

Tel: +44 (0) 20 7886 2500

Allenby Capital Limited (Joint Broker)

Nick Athanas, Corporate Finance

Amrit Nahal / Tony Quirke, Sales & Corporate Broking

Tel: +44 (0) 20 3328 5656

 

TooleyStreet Communications Limited (Investor and media relations)

Fiona Tooley

Tel: +44 (0) 7785 703523

Email: fiona@tooleystreet.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBUGDDLGGDGLD
Date   Source Headline
12th Feb 20107:00 amRNSTransaction in Own Shares
11th Feb 20107:00 amRNSTransaction in Own Shares
10th Feb 20107:00 amRNSTransaction in Own Shares
9th Feb 20109:11 amRNSHolding(s) in Company
9th Feb 20107:00 amRNSTransaction in Own Shares
8th Feb 20107:00 amRNSTransaction in Own Shares
5th Feb 201012:25 pmRNSDirector/PDMR Shareholding
5th Feb 20107:00 amRNSTransaction in Own Shares
4th Feb 20107:00 amRNSTransaction in Own Shares
2nd Feb 20107:00 amRNSTransaction in Own Shares
1st Feb 20109:00 amRNSTransaction in Own Shares
29th Jan 20107:00 amRNSTransaction in Own Shares
28th Jan 201011:54 amRNSDirector/PDMR Shareholding
28th Jan 20107:41 amRNSTransaction in Own Shares
27th Jan 20109:12 amRNSBuy back programme
26th Jan 20107:00 amRNSPlans to Launch Official Michael Jackson Dolls
21st Jan 20103:57 pmRNSResult of AGM
20th Jan 20107:00 amRNSTrading Update
24th Dec 200910:59 amRNSAnnual Report and Accounts
7th Dec 20092:47 pmRNSStatement re. Press Comment
1st Dec 20097:00 amRNSPreliminary Results
26th Nov 20091:35 pmRNSNotice of Results
28th Oct 20099:36 amRNSDouble Success for Character in Dream Toys 2009
29th Sep 20096:32 pmRNSDirector/PDMR Shareholding
24th Sep 200912:47 pmRNSHolding(s) in Company
4th Sep 20092:15 pmRNSBlocklisting Interim Review
1st Sep 20091:50 pmRNSHolding(s) in Company
31st Jul 20095:45 pmRNSTotal Voting Rights
10th Jul 20091:04 pmRNSHolding(s) in Company
7th Jul 200911:53 amRNSPossible Dealing
7th May 200911:24 amRNSDirector/PDMR Shareholding
7th May 200911:23 amRNSDirector/PDMR Shareholding
7th May 200911:20 amRNSDirector/PDMR Shareholding
7th May 200911:20 amRNSDirector/PDMR Shareholding
6th May 20095:36 pmRNSDirector/PDMR Shareholding
6th May 20095:35 pmRNSDirector/PDMR Shareholding
6th May 20095:33 pmRNSDirector/PDMR Shareholding
6th May 20095:32 pmRNSDirector/PDMR Shareholding
30th Apr 20094:31 pmRNSHolding(s) in Company
28th Apr 20097:00 amRNSInterim Results
24th Mar 20094:40 pmRNSSecond Price Monitoring Extn
24th Mar 20094:35 pmRNSPrice Monitoring Extension
18th Mar 20095:10 pmRNSIssue of Equity
17th Mar 20094:35 pmRNSPrice Monitoring Extension
6th Mar 20094:35 pmRNSPrice Monitoring Extension
2nd Mar 20095:54 pmRNSBlocklisting Interim Review
21st Jan 200912:11 pmRNSResult of AGM
21st Jan 200911:00 amRNSTrading Update
24th Dec 20088:18 amRNSAnnual Report and Accounts
18th Dec 20081:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.